Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab in Northeast Asia SLE Patients
NCT01345253Phase 3Completed
- Sponsor
- GSK
- Start
- May 2011
- Primary completion
- Sep 2015
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 3 trial of belimumab in systemic lupus erythematosus (SLE), sponsored by GSK. Started May 2011; status: completed.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01345253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01345253.